Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Proteoform-Specific Drug Interactions in Native Membranes
2026-09-17
The reference study introduces a native mass-spectrometry strategy for defining how membrane-protein proteoforms, lipid modifications, and drug interactions are linked in intact signaling environments. Its analysis of rhodopsin, G proteins, and PDE6 shows why off-target pharmacology can depend on proteoform state rather than protein identity alone.
-
Cy5-UTP for Fluorescent RNA Labeling
2026-09-16
Cy5-UTP, also called Cyanine 5-uridine triphosphate, is a fluorescent UTP analog for T7 in vitro transcription RNA labeling. Its reported 650/670 nm excitation/emission maxima support direct detection of labeled RNA, while the axonal RNP study provides a biological rationale for tracing RNA-associated transport without demonstrating use of this reagent.
-
Tetrazolium Red: From Redox Signal to Translation
2026-09-16
Tetrazolium (chloride) is more than a viability stain: it is a strategic redox endpoint for connecting mitochondrial dehydrogenase activity with tissue injury, therapeutic response, and translational decision-making. This article examines its mechanistic value, experimental limits, and application in ischemic stroke research.
-
Flavopiridol: Reliable CDK Assay Workflows
2026-09-15
Learn how Flavopiridol (SKU A3417) can help separate CDK-mediated cell-cycle arrest from nonspecific loss of viability in cancer research assays. This scenario-based guide covers dose design, solvent compatibility, ER-stress interpretation, and practical product-selection criteria.
-
DAPI Nuclear Stain Solution: Practical Protocol
2026-09-15
DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution provides a ready-to-use fluorescent DNA binding dye for nuclear visualization and endpoint assessment of membrane-compromised cells. It is intended for fixed-sample fluorescence microscopy and flow cytometry workflows, not routine imaging of intact live cells.
-
Carbenoxolone disodium: Practical No-Paper Guide
2026-09-14
Carbenoxolone disodium is a research tool for perturbing 11β-hydroxysteroid dehydrogenase activity, glucocorticoid access, and gap junction communication in cell- and tissue-based workflows. Use it with matched vehicle, viability, formulation, and orthogonal pathway controls; do not treat the compound as a selective in vivo efficacy probe when directly matched paper evidence is unavailable.
-
(S)-(+)-Ibuprofen: COX Inhibitor Workflows
2026-09-14
Build cleaner inflammation assays with the pharmacologically active ibuprofen enantiomer, from COX target-engagement studies to cell-based prostaglandin readouts. The same compound also supports a controlled environmental toxicology workflow when concentration, matrix effects, and biodegradation are measured separately.
-
Leucovorin Calcium for Gastric Cancer Assembloids
2026-09-13
Leucovorin Calcium, also called calcium folinate, turns methotrexate rescue into a mechanistic tool for separating tumor-intrinsic sensitivity from stromal protection. This workflow applies controlled folate rescue to patient-derived gastric cancer assembloids, improving interpretation of viability, resistance, and tumor–stroma interactions.
-
Pseudo-UTP: From RNA Chemistry to Translation Strategy
2026-09-12
A translational framework for combining pseudouridine chemistry with UTR engineering to improve mRNA design, experimental rigor, and development decisions without overstating preclinical evidence.
-
Carbapenemase Gene Dynamics in CREC
2026-09-11
A 2025 multicenter study mapped carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae from eight teaching hospitals in Guangdong, combining gene-localization, susceptibility, conjugation, mobile-element, and genotyping analyses. Its findings identify plasmid-associated blaNDM-1 and efficient horizontal transfer as central risks for multidrug-resistant CREC dissemination, while also clarifying the limits of hospital-based molecular epidemiology.
-
Canagliflozin Workflows for Renal Mitochondria
2026-09-11
Canagliflozin enables target-linked studies that connect renal glucose reabsorption inhibition with proximal-tubule mitochondrial remodeling. This practical guide covers compound handling, diabetic-mouse workflows, bioenergetic assays, sex-aware interpretation, and troubleshooting for more reproducible SGLT2 inhibitor research.
-
Endoplasmic Reticulum Stress and Intestinal Stem Cells
2026-09-10
The reference study links tunicamycin-induced endoplasmic reticulum stress with intestinal stem cell loss, impaired epithelial differentiation, reduced crypt proliferation, and increased apoptosis in mice. Its central mechanistic contribution is the association of these effects with GRP78/ATF6/CHOP activation and suppression of p44/42 MAPK signaling, while also highlighting important limits of pharmacological stress models.
-
CD44-Copper Signaling in Ly6Chi Macrophages
2026-09-10
The reference study links CD44 upregulation and impaired ATP7A-mediated copper export to copper accumulation, ROS elevation, and inflammatory activation of Ly6Chi macrophages in ulcerative colitis. By integrating single-cell transcriptomics, proteomics, mouse intervention, and macrophage experiments, it proposes copper handling as a mechanistic bridge between macrophage state and intestinal inflammation.
-
Recent Advances in Ibuprofen and Naproxen Synthesis
2026-09-09
Ha and Paek’s review maps how ibuprofen and naproxen synthesis has advanced through shorter routes, asymmetric methods, improved process conditions, and continuous-flow chemistry. Its practical value lies in connecting route design with stereochemical control, scalability, safety, and access to derivatives for ongoing nonsteroidal anti-inflammatory drug research.
-
Locally Produced DENV-1 RT-LAMP Diagnostics
2026-09-09
The 2025 reference study describes a recombinant enzyme system and primer set for DENV-1 RT-LAMP that can be produced and stabilized locally, addressing supply-chain barriers in endemic, resource-limited settings. Its most important analytical result was detection at 10 copies in the reported assay, with turbidity providing a simple positive-versus-negative readout rather than requiring fluorescence instrumentation.